3 Pharmacy Chain, Zinc Oxide and Household Product Stocks With a Strong Future Roadmap: Medplus Health Services, JG Chemicals and Godrej Consumer Products

Pharmacy chain, zinc oxide and household product stocks give investors exposure to medicines, industrial chemicals and household products bought every day. Volumes, pricing and margins decide how much of that demand turns into profit.

This list covers three pharmacy chain, zinc oxide and household product stocks: Medplus Health Services for a pharmacy retail chain with stores across several states, JG Chemicals for zinc oxide used in tyres, ceramics, paints and other industrial products and Godrej Consumer Products for household insecticides, soaps and hair colour sold in India, Indonesia and Africa. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Pharmacy Chain, Zinc Oxide and Household Product Stocks?

Pharmacy chain, zinc oxide and household product stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Pharmacy Chain, Zinc Oxide and Household Product Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three pharmacy chain, zinc oxide and household product stocks as of the 14 Oct 2026 close.

Among healthcare, chemicals and consumer stocks, Godrej Consumer trades at a premium to the industry P/E, while Medplus and JG Chemicals trade at a discount.

Why Do Pharmacy Chain, Zinc Oxide and Household Product Stocks Have a Strong Roadmap in India?

Pharmacy chain, zinc oxide and household product stocks have a strong roadmap in India because pharmacy store additions, tyre and paint output and household brand spending keep adding volumes for these firms. Three drivers stand out.

• Pharmacy reach: New stores bring medicines closer to homes.
• Industrial use: Tyres, ceramics and paints consume zinc oxide.
• Household brands: Home care and personal care sell across markets.

Medplus Health Services: Pharmacy Retail Stores Anchor the Roadmap

Medplus' roadmap rests on a pharmacy retail chain with stores across several states, with store expansion supporting revenue.

Revenue grew from Rs 3,810.64 crore in FY22 to Rs 6,963.79 crore in FY26, an 82.7% rise, and FY26 revenue was 12.6% higher than FY25. FY26 net profit rose 46.2% to Rs 219.61 crore. Over four years, net profit rose from Rs 94.72 crore in FY22 to Rs 219.61 crore. In Q1 FY27, revenue grew 21.9% to Rs 1,899.43 crore. Operating margin was 9.85% in FY26.

Debt to equity is 0.72 and return on equity is 11.12%. FY26 operating cash flow was Rs 495.58 crore against capital expenditure of Rs 123.03 crore. At a P/E of 36.06 against an industry P/E of 66.59, the stock trades below its industry multiple.

What to watch: Net profit margin is only 3.2%, so small cost changes move earnings.

JG Chemicals: Zinc Oxide Demand Builds the Next Leg

JG Chemicals' roadmap rests on zinc oxide used in tyres, ceramics, paints and other industrial products, with steady industrial demand supporting volumes.

Revenue grew from Rs 623.05 crore in FY22 to Rs 988.77 crore in FY26, a 58.7% rise, and FY26 revenue was 15.2% higher than FY25. FY26 net profit rose 2.8% to Rs 68.65 crore. Over four years, net profit rose from Rs 43.13 crore in FY22 to Rs 68.65 crore. In Q1 FY27, revenue grew 43.8% to Rs 318.38 crore, and net profit rose 59.7% to Rs 26.12 crore. Operating margin was 10.09% in FY26 and 11.48% in Q1 FY27 against 10.65% a year earlier.

Debt to equity is 0.01 and return on equity is 12.47%. FY26 operating cash flow was Rs 43.57 crore against capital expenditure of Rs 39.03 crore. The dividend yield is 0.16%. At a P/E of 31.94 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 11.48% against 10.09% for FY26, so margin stability is the figure to follow as volumes grow.

Godrej Consumer Products: Household and Personal Care Brands Drive the Pipeline

Godrej Consumer's roadmap rests on household insecticides, soaps and hair colour sold in India, Indonesia and Africa, with a multi-country brand portfolio supporting sales.

Revenue grew from Rs 12,366.21 crore in FY22 to Rs 15,444.07 crore in FY26, a 24.9% rise, and FY26 revenue was 7.9% higher than FY25. FY26 net profit was Rs 1,861.47 crore. In Q1 FY27, revenue grew 14.2% to Rs 4,277.35 crore, and net profit rose 11.5% to Rs 504.52 crore. Operating margin was 19.45% in FY26.

Debt to equity is 0.35 and return on equity is 14.71%. FY26 operating cash flow was Rs 2,488.47 crore against capital expenditure of Rs 569.53 crore. Godrej Consumer paid a dividend of Rs 20 per share for FY26, a yield of 2.31%. At a P/E of 46.25 against an industry P/E of 34.85, the stock trades above its industry multiple.

What to watch: The P/E of 46.25 sits above the industry P/E of 34.85, so earnings delivery matters for the valuation.

Best Pharmacy Chain, Zinc Oxide and Household Product Stocks in India: Medplus vs JG Chemicals vs Godrej Consumer on Key Financials

Among the best pharmacy chain, zinc oxide and household product stocks in India, Medplus ranks second on FY26 revenue growth and Q1 FY27 revenue growth; JG Chemicals leads on FY26 revenue growth and Q1 FY27 revenue growth; Godrej Consumer leads on FY26 operating margin and return on equity. The table puts the numbers side by side.

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Pharmacy Chain, Zinc Oxide and Household Product Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen pharmacy chain, zinc oxide and household product stocks and shortlist pharmacy chain, zinc oxide and household product stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these pharmacy chain, zinc oxide and household product stocks

Risks to Consider Before Investing in Pharmacy Chain, Zinc Oxide and Household Product Stocks

• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Medplus, JG Chemicals and Godrej Consumer live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover pharmacies, zinc oxide and household brands. Medplus ranks second on FY26 revenue growth and Q1 FY27 revenue growth; JG Chemicals leads on FY26 revenue growth and Q1 FY27 revenue growth; Godrej Consumer leads on FY26 operating margin and return on equity.

Across pharmacy chain, zinc oxide and household product stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the pharmacy chain, zinc oxide and household product stocks to buy discussed here.

FAQs on Pharmacy Chain, Zinc Oxide and Household Product Stocks

Which are the best pharmacy chain, zinc oxide and household product stocks in India with a strong roadmap?

Ans. Medplus Health Services, JG Chemicals and Godrej Consumer Products stand out for their roadmaps in pharmacies, zinc oxide and household brands. FY26 revenue growth was 12.6% at Medplus, 15.2% at JG Chemicals and 7.9% at Godrej Consumer, and return on equity ranges from 11.12% to 14.71%.

Is Medplus Health Services a good stock to buy now?

Ans. Medplus Health Services has a debt to equity ratio of 0.72, a return on equity of 11.12% and a P/E of 36.06 against an industry P/E of 66.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Medplus, JG Chemicals and Godrej Consumer?

Ans. The P/E ratio is 36.06 for Medplus (industry 66.59), 31.94 for JG Chemicals (industry 36.60) and 46.25 for Godrej Consumer (industry 34.85). Only Godrej Consumer trades at or above the industry multiple.

Which of these pharmacy chain, zinc oxide and household product stocks has the highest return on equity?

Ans. Godrej Consumer Products has the highest return on equity at 14.71%, followed by JG Chemicals at 12.47% and Medplus Health Services at 11.12%.

What are the risks of investing in pharmacy chain, zinc oxide and household product stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Medplus, JG Chemicals and Godrej Consumer perform in Q1 FY27?

Ans. Medplus Health Services reported revenue of Rs 1,899.43 crore, up 21.9% year on year. JG Chemicals reported revenue of Rs 318.38 crore, up 43.8% year on year, and net profit rose 59.7% to Rs 26.12 crore. Godrej Consumer Products reported revenue of Rs 4,277.35 crore, up 14.2% year on year, and net profit rose 11.5% to Rs 504.52 crore.

Do pharmacy chain, zinc oxide and household product stocks pay dividends?

Ans. JG Chemicals and Godrej Consumer pay dividends. The dividend yield is 0.16% for JG Chemicals and 2.31% for Godrej Consumer, based on dividends declared for FY26.

How can I invest in pharmacy chain, zinc oxide and household product stocks in India?

Ans. You can buy pharmacy chain, zinc oxide and household product stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.